Perisomatic Inhibition and Its Relation to Epilepsy and to Synchrony Generation in the Human Neocortex.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Dec 2021
Historique:
received: 17 11 2021
revised: 21 12 2021
accepted: 22 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 4 2 2022
Statut: epublish

Résumé

Inhibitory neurons innervating the perisomatic region of cortical excitatory principal cells are known to control the emergence of several physiological and pathological synchronous events, including epileptic interictal spikes. In humans, little is known about their role in synchrony generation, although their changes in epilepsy have been thoroughly investigated. This paper demonstraits how parvalbumin (PV)- and type 1 cannabinoid receptor (CB1R)-positive perisomatic interneurons innervate pyramidal cell bodies, and their role in synchronous population events spontaneously emerging in the human epileptic and non-epileptic neocortex, in vitro. Quantitative electron microscopy showed that the overall, PV+ and CB1R+ somatic inhibitory inputs remained unchanged in focal cortical epilepsy. On the contrary, the size of PV-stained synapses increased, and their number decreased in epileptic samples, in synchrony generating regions. Pharmacology demonstrated-in conjunction with the electron microscopy-that although both perisomatic cell types participate, PV+ cells have stronger influence on the generation of population activity in epileptic samples. The somatic inhibitory input of neocortical pyramidal cells remained almost intact in epilepsy, but the larger and consequently more efficient somatic synapses might account for a higher synchrony in this neuron population. This, together with epileptic hyperexcitability, might make a cortical region predisposed to generate or participate in hypersynchronous events.

Identifiants

pubmed: 35008628
pii: ijms23010202
doi: 10.3390/ijms23010202
pmc: PMC8745731
pii:
doi:

Substances chimiques

Parvalbumins 0
Receptors, Cannabinoid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research, Development and Innovation Office
ID : K119443, PD121123, K137886
Organisme : Hungarian Brain Research Program
ID : 2017-1.2.1-NKP-2017-00002, KTIA-NAP17-3-2017-0001
Organisme : European Social Fund
ID : EFOP-3.6.2-16-2017-00008

Références

Nat Neurosci. 2018 Sep;21(9):1185-1195
pubmed: 30150662
Neuropsychopharmacology. 2012 Apr;37(5):1104-14
pubmed: 22048459
Prog Neurobiol. 2005 Oct;77(3):166-200
pubmed: 16307840
Curr Opin Neurobiol. 2015 Apr;31:26-32
pubmed: 25128735
J Comp Neurol. 1993 Nov 8;337(2):208-30
pubmed: 8276998
Prog Brain Res. 2004;145:109-20
pubmed: 14650910
J Clin Neurophysiol. 2015 Jun;32(3):227-34
pubmed: 26035675
Epilepsy Res. 2010 Mar;89(1):52-9
pubmed: 20149961
J Physiol. 1996 Apr 15;492 ( Pt 2):479-93
pubmed: 9019544
Curr Med Chem. 2014;21(6):663-88
pubmed: 24251566
Biomed Res Int. 2017;2017:7154295
pubmed: 28116310
Neuroscience. 2002;115(3):961-78
pubmed: 12435433
J Neurosci. 2004 Apr 14;24(15):3879-89
pubmed: 15084669
Nat Neurosci. 2012 Jun 10;15(7):988-97
pubmed: 22683683
Curr Opin Neurobiol. 1994 Aug;4(4):569-79
pubmed: 7812147
J Neurosci. 2005 Nov 2;25(44):10308-20
pubmed: 16267239
PLoS Biol. 2016 Nov 9;14(11):e2000237
pubmed: 27828957
Neuroscience. 2012 Oct 25;223:399-411
pubmed: 22863677
Neurophotonics. 2014 Jul;1(1):011013
pubmed: 26157969
J Physiol. 2017 Mar 1;595(5):1711-1723
pubmed: 27861914
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13311-6
pubmed: 9371842
J Physiol. 2018 Jan 15;596(2):317-342
pubmed: 29178354
J Physiol. 2016 Jul 1;594(13):3745-74
pubmed: 27038232
Neuroscience. 1998 Jan;82(2):355-76
pubmed: 9466448
Hippocampus. 1991 Jan;1(1):41-66
pubmed: 1688284
Epilepsy Res. 1994 Mar;17(3):185-92
pubmed: 8013442
Eur J Neurosci. 2010 Jun;31(12):2234-46
pubmed: 20529124
J Neurosci. 2008 Mar 19;28(12):2976-90
pubmed: 18354002
Neuroscience. 2005;131(2):557-66
pubmed: 15708496
J Neurosci. 1999 Jun 1;19(11):4544-58
pubmed: 10341254
Eur J Neurosci. 2000 Sep;12(9):3239-49
pubmed: 10998107
Neuron. 2007 Oct 4;56(1):33-42
pubmed: 17920013
Cereb Cortex. 2007 Jan;17(1):175-91
pubmed: 16467563
Neuroscience. 2010 Sep 29;170(1):28-41
pubmed: 20621164
Epilepsy Res. 2011 Dec;97(3):308-17
pubmed: 21482073
Annu Rev Physiol. 2001;63:815-46
pubmed: 11181977
Trends Neurosci. 2003 Sep;26(9):489-95
pubmed: 12948660
Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S60-5
pubmed: 18336996
Eur J Neurosci. 2003 Apr;17(7):1403-10
pubmed: 12713643
BMC Neurosci. 2012 Apr 27;13:42
pubmed: 22540185
J Physiol. 2019 Dec;597(23):5639-5670
pubmed: 31523807
Prog Neurobiol. 1996 Apr;48(6):519-54
pubmed: 8809907
J Neurosci. 2009 Aug 5;29(31):9888-902
pubmed: 19657040
PLoS Biol. 2008 Sep 2;6(9):e222
pubmed: 18767905
Prog Neurobiol. 2001 Apr;63(5):541-67
pubmed: 11164621
J Neurosci. 2001 Oct 15;21(20):7993-8003
pubmed: 11588172
Exp Brain Res. 1997 Mar;114(1):1-10
pubmed: 9125446
Cereb Cortex. 2015 Mar;25(3):578-97
pubmed: 24046077
Physiol Rev. 2003 Jul;83(3):1017-66
pubmed: 12843414
Hippocampus. 2015 Feb;25(2):169-86
pubmed: 25209976
Neuroscience. 2001;108(4):587-600
pubmed: 11738496
Brain. 2005 Jan;128(Pt 1):138-52
pubmed: 15548550
Ann Neurol. 2019 Nov;86(5):714-728
pubmed: 31393618
J Comp Neurol. 1994 Apr 15;342(3):389-408
pubmed: 7517410
Brain. 2009 Nov;132(Pt 11):3032-46
pubmed: 19767413
Epilepsia. 2010 Jul;51 Suppl 3:115-20
pubmed: 20618415
Prog Neurobiol. 2002 Oct;68(3):167-207
pubmed: 12450487
Nat Neurosci. 2020 Dec;23(12):1456-1468
pubmed: 32839617
J Neurosci. 2013 Jul 10;33(28):11677-91
pubmed: 23843535
Science. 2008 Jul 4;321(5885):53-7
pubmed: 18599766
Brain. 1998 Jun;121 ( Pt 6):1073-87
pubmed: 9648543
J Comp Neurol. 2014 Apr 1;522(5):986-1003
pubmed: 23983014
Science. 1993 Jan 1;259(5091):97-100
pubmed: 8093417
Brain. 2014 Feb;137(Pt 2):463-85
pubmed: 24390441
Sci Transl Med. 2014 Jul 9;6(244):244ra89
pubmed: 25009229
Can J Physiol Pharmacol. 1997 May;75(5):479-87
pubmed: 9250381
J Neurosci. 2014 Aug 20;34(34):11385-98
pubmed: 25143618
Eur J Neurosci. 2004 May;19(10):2682-92
pubmed: 15147302
Sci Rep. 2016 Mar 16;6:23176
pubmed: 26980663
Int J Mol Sci. 2020 Dec 10;21(24):
pubmed: 33321734
Trends Neurosci. 2008 Jul;31(7):317-27
pubmed: 18556072
Epilepsy Res. 1998 Sep;32(1-2):93-103
pubmed: 9761312
Front Neuroanat. 2017 Sep 26;11:83
pubmed: 29018334
J Physiol. 1971 May;215(1):247-68
pubmed: 5579661
J Neurophysiol. 2006 Apr;95(4):2155-66
pubmed: 16421199
Brain Res Bull. 2006 Feb 15;68(6):474-81
pubmed: 16459206
Neuroscience. 1991;44(1):157-71
pubmed: 1770994
Eur J Neurosci. 1999 Dec;11(12):4213-25
pubmed: 10594647
J Neurosci. 2005 Oct 19;25(42):9782-93
pubmed: 16237182
Neuron. 1996 Apr;16(4):815-23
pubmed: 8607999
J Neurophysiol. 2007 Aug;98(2):952-65
pubmed: 17581851
Neurobiol Dis. 2012 Jul;47(1):102-13
pubmed: 22484482
Hippocampus. 1996;6(4):347-470
pubmed: 8915675
J Neurosci. 2006 May 24;26(21):5628-37
pubmed: 16723519
Brain Res Bull. 1997;44(1):47-66
pubmed: 9288831
Cereb Cortex. 1993 Jan-Feb;3(1):39-48
pubmed: 7679938
Epilepsia. 2012 Nov;53(11):1987-97
pubmed: 22957946
Front Neural Circuits. 2017 Dec 08;11:100
pubmed: 29276477
Trends Neurosci. 2005 Jun;28(6):334-40
pubmed: 15927690
J Neurosci. 2006 Apr 26;26(17):4535-45
pubmed: 16641233

Auteurs

Estilla Zsófia Tóth (EZ)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.
Szentágothai János Doctoral School, Semmelweis University, 1026 Budapest, Hungary.

Felicia Gyöngyvér Szabó (FG)

Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, 1083 Budapest, Hungary.

Ágnes Kandrács (Á)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.

Noémi Orsolya Molnár (NO)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.
Szentágothai János Doctoral School, Semmelweis University, 1026 Budapest, Hungary.

Gábor Nagy (G)

National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Attila G Bagó (AG)

National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Loránd Erőss (L)

National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Dániel Fabó (D)

National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Boglárka Hajnal (B)

Szentágothai János Doctoral School, Semmelweis University, 1026 Budapest, Hungary.
National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Bence Rácz (B)

Department of Anatomy and Histology, University of Veterinary Medicine, 1078 Budapest, Hungary.

Lucia Wittner (L)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.
Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, 1083 Budapest, Hungary.
National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

István Ulbert (I)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.
Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, 1083 Budapest, Hungary.
National Institute of Mental Health, Neurology and Neurosurgery, 1145 Budapest, Hungary.

Kinga Tóth (K)

Research Center for Natural Sciences, Institute of Cognitive Neuroscience and Psychology, Eötvös Loránd Research Network, 1117 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH